Tenor Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Tenor Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,000	Closed	-$267K	–	41
2016 Q1	$267K	Buy	+5,000	New	+$369K	0.07%	38

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Tenor Capital Management's ANAC Position: Q2 2016 in Review

Tenor Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 5,000 shares — an estimated $267K sold.

Tenor Capital Management first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $267K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Tenor Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Tenor Capital Management sold 5,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $267K.
Tenor Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Tenor Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $267K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Tenor Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.